InvestorsHub Logo
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

Re: None

Monday, 06/06/2016 2:02:47 PM

Monday, June 06, 2016 2:02:47 PM

Post# of 2099
Two questions about the ovarian cancer data....

One, is their a chance in hell(I doubt it), but will throw this out there.... could the ovarian cancer data be sufficiently compelling to pursue accelerated approval for this platinum resistant ovarian cancer patents who also failed Avastin? It's a long shot due to the tiny sample size, but who knows.

Second, would today's ovarian cancer data constitute breakthrough designation under the FDA program.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News